OpenURL Connection Search

Select item for more details and to access through your institution.

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.
Published in:
PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128151
By:
- Deniger, Drew C.;
- Yu, Jianqiang;
- Huls, M. Helen;
- Figliola, Matthew J.;
- Mi, Tiejuan;
- Maiti, Sourindra N.;
- 2ndWidhopf, George F.;
- Hurton, Lenka V.;
- Thokala, Radhika;
- Singh, Harjeet;
- Olivares, Simon;
- Champlin, Richard E.;
- Wierda, William G.;
- Kipps, Thomas J.;
- Cooper, Laurence J. N.
Publication type:
Article
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.664236
By:
- Thokala, Radhika;
- Binder, Zev A.;
- Yin, Yibo;
- Zhang, Logan;
- Zhang, Jiasi Vicky;
- Zhang, Daniel Y.;
- Milone, Michael C.;
- Ming, Guo-li;
- Song, Hongjun;
- O'Rourke, Donald M.
Publication type:
Article
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors.
Published in:
PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0159477
By:
- Thokala, Radhika;
- Olivares, Simon;
- Mi, Tiejuan;
- Maiti, Sourindra;
- Deniger, Drew;
- Huls, Helen;
- Torikai, Hiroki;
- Singh, Harjeet;
- Champlin, Richard E.;
- Laskowski, Tamara;
- McNamara, George;
- Cooper, Laurence J. N.
Publication type:
Article

Found: 3

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms.

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of V<sub>L</sub> and V<sub>H</sub> Domains Targeting CD123<sup>+</sup> Tumors.